Pharmacokinetics of serelaxin in patients with severe renal impairment or end‐stage renal disease requiring hemodialysis: A single‐dose, open‐label, parallel‐group study

Marion Dahlke; Atef Halabi; Jasna Canadi; Chiaki Tsubouchi; Surendra Machineni; Yinuo Pang

doi:10.1002/jcph.607

Pharmacokinetics of serelaxin in patients with severe renal impairment or end‐stage renal disease requiring hemodialysis: A single‐dose, open‐label, parallel‐group study

The Journal of Clinical Pharmacology ◽

10.1002/jcph.607 ◽

2015 ◽

Vol 56 (4) ◽

pp. 474-483 ◽

Cited By ~ 14

Author(s):

Marion Dahlke ◽

Atef Halabi ◽

Jasna Canadi ◽

Chiaki Tsubouchi ◽

Surendra Machineni ◽

...

Keyword(s):

Single Dose ◽

Renal Impairment ◽

Renal Disease ◽

End Stage Renal Disease ◽

Severe Renal Impairment ◽

Open Label ◽

Parallel Group Study ◽

Parallel Group ◽

Stage Renal Disease ◽

End Stage

Download Full-text

Single-Dose, Open-Label Study of the Differences in Pharmacokinetics of Colchicine in Subjects with Renal Impairment, Including End-Stage Renal Disease

Clinical Drug Investigation ◽

10.1007/s40261-014-0238-6 ◽

2014 ◽

Vol 34 (12) ◽

pp. 845-855 ◽

Cited By ~ 15

Author(s):

Suman Wason ◽

David Mount ◽

Robert Faulkner

Keyword(s):

Single Dose ◽

Renal Impairment ◽

Renal Disease ◽

End Stage Renal Disease ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Stage Renal Disease ◽

End Stage

Download Full-text

Single-Dose, Open-Label Study of the Differences in Pharmacokinetics of Colchicine in Subjects with Renal Impairment, Including End-Stage Renal Disease

Clinical Drug Investigation ◽

10.1007/s40261-014-0262-6 ◽

2014 ◽

Vol 35 (2) ◽

pp. 149-149

Author(s):

Yalcin Solak ◽

Seyyid Bilal Acikgoz ◽

Mehmet Yildirim

Keyword(s):

Single Dose ◽

Renal Impairment ◽

Renal Disease ◽

End Stage Renal Disease ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Stage Renal Disease ◽

End Stage

Download Full-text

1027 AN OPEN-LABEL, SINGLE-DOSE, PHASE 1 STUDY OF THE PHARMACOKINETICS AND SAFETY OF JZP-110 IN SUBJECTS WITH NORMAL OR IMPAIRED RENAL FUNCTION AND WITH END-STAGE RENAL DISEASE REQUIRING HEMODIALYSIS

SLEEP ◽

10.1093/sleepj/zsx050.1026 ◽

2017 ◽

Vol 40 (suppl_1) ◽

pp. A382-A382 ◽

Cited By ~ 2

Author(s):

K Zomorodi ◽

D Chen ◽

L Lee ◽

K Lasseter ◽

T Marbury

Keyword(s):

Renal Function ◽

Single Dose ◽

Renal Disease ◽

End Stage Renal Disease ◽

Impaired Renal Function ◽

Phase 1 ◽

Open Label ◽

Phase 1 Study ◽

Stage Renal Disease ◽

End Stage

Download Full-text

Serum inhibitory and bactericidal activity of telavancin in non-infected subjects with severe renal impairment or end-stage renal disease

Diagnostic Microbiology and Infectious Disease ◽

10.1016/j.diagmicrobio.2014.09.002 ◽

2014 ◽

Vol 80 (4) ◽

pp. 327-329 ◽

Cited By ~ 8

Author(s):

Steven L. Barriere ◽

David J. Farrell ◽

Paul R. Rhomberg ◽

Ronald N. Jones

Keyword(s):

Renal Impairment ◽

Renal Disease ◽

Bactericidal Activity ◽

End Stage Renal Disease ◽

Severe Renal Impairment ◽

Stage Renal Disease ◽

End Stage

Download Full-text

LO1 : Safety of ombitasvir/paritaprevir/ritonavir plus dasabuvir for treating HCV GT1 infection in patients with severe renal impairment or end-stage renal disease: The RUBY-I study

Journal of Hepatology ◽

10.1016/s0168-8278(15)30147-1 ◽

2015 ◽

Vol 62 ◽

pp. S257 ◽

Cited By ~ 51

Author(s):

P.J. Pockros ◽

K.R. Reddy ◽

P.S. Mantry ◽

E. Cohen ◽

M. Bennett ◽

...

Keyword(s):

Renal Impairment ◽

Renal Disease ◽

End Stage Renal Disease ◽

Severe Renal Impairment ◽

Stage Renal Disease ◽

End Stage

Download Full-text

Pharmacokinetics of fingolimod and metabolites in subjects with severe renal impairment: An open-label, single-dose, parallel-group study

International Journal of Clinical Pharmacology and Therapeutics ◽

10.5414/cp202356 ◽

2015 ◽

Vol 53 (10) ◽

pp. 847-854 ◽

Cited By ~ 2

Author(s):

Olivier J. David ◽

Maxwell Pryce ◽

Karin Meiser ◽

Franck Picard ◽

Corinne Emotte ◽

...

Keyword(s):

Single Dose ◽

Renal Impairment ◽

Severe Renal Impairment ◽

Open Label ◽

Parallel Group Study ◽

Parallel Group

Download Full-text

The pharmacokinetics (PK) of aprepitant are not affected in patients with end-stage renal disease (ESRD) or severe renal impairment

Inpharma Weekly ◽

10.2165/00128413-200514940-00044 ◽

2005 ◽

Vol &NA; (1494) ◽

pp. 19

Author(s):

&NA;

Keyword(s):

Renal Impairment ◽

Renal Disease ◽

End Stage Renal Disease ◽

Severe Renal Impairment ◽

Stage Renal Disease ◽

End Stage

Download Full-text

Pharmacokinetics, safety, and tolerability of siponimod (BAF312) in subjects with severe renal impairment: A single-dose, open-label, parallel-group study

International Journal of Clinical Pharmacology and Therapeutics ◽

10.5414/cp202608 ◽

2017 ◽

Vol 55 (01) ◽

pp. 54-65 ◽

Cited By ~ 6

Author(s):

Anne Gardin ◽

Angela Dodman ◽

Sampath Kalluri ◽

Srikanth Neelakantham ◽

Xuemei Tan ◽

...

Keyword(s):

Single Dose ◽

Renal Impairment ◽

Severe Renal Impairment ◽

Open Label ◽

Parallel Group Study ◽

Parallel Group

Download Full-text

1101 THE EFFECT OF RENAL IMPAIRMENT AND END STAGE RENAL DISEASE ON THE SINGLE-DOSE PHARMACOKINETICS OF PSI-7977

Journal of Hepatology ◽

10.1016/s0168-8278(12)61113-1 ◽

2012 ◽

Vol 56 ◽

pp. S433 ◽

Cited By ~ 42

Author(s):

M.T. Cornpropst ◽

J.M. Denning ◽

D. Clemons ◽

T.C. Marbury ◽

H. Alcorn ◽

...

Keyword(s):

Single Dose ◽

Renal Impairment ◽

Renal Disease ◽

End Stage Renal Disease ◽

Stage Renal Disease ◽

End Stage

Download Full-text

An open-label, non-randomised, phase 1, single-dose study to assess the pharmacokinetics of ceftaroline in patients with end-stage renal disease requiring intermittent haemodialysis

International Journal of Antimicrobial Agents ◽

10.1016/j.ijantimicag.2015.09.009 ◽

2015 ◽

Vol 46 (6) ◽

pp. 682-688 ◽

Cited By ~ 2

Author(s):

Maria Sunzel ◽

Maria Learoyd ◽

Jianguo Li ◽

Yan Li ◽

Ngoc Ngo ◽

...

Keyword(s):

Single Dose ◽

Renal Disease ◽

End Stage Renal Disease ◽

Phase 1 ◽

Open Label ◽

Single Dose Study ◽

Intermittent Haemodialysis ◽

Dose Study ◽

Stage Renal Disease ◽

End Stage

Download Full-text